Stockreport

Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market

VACCINEX INC  (VCNX) 
PDF ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a diffe [Read more]